EFFECT OF 2 NOVEL INHIBITORS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE ON THE MATURATION OF THE HIV GAG AND GAG-POL POLYPROTEINS

被引:21
|
作者
OVERTON, HA [1 ]
MCMILLAN, DJ [1 ]
GRIDLEY, SJ [1 ]
BRENNER, J [1 ]
REDSHAW, S [1 ]
MILLS, JS [1 ]
机构
[1] ROCHE PROD LTD,DEPT CHEM,WELWYN GARDEN CIT AL7 3AY,HERTS,ENGLAND
关键词
D O I
10.1016/0042-6822(90)90326-M
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ability of two novel synthetic compounds to inhibit the HIV protease-mediated processing of HIV-1 precursor polyproteins was investigated in an in vitro gag-protease mixed lysate assay system and in an assay using recombinant baculoviruses engineered to express the HIV-1 gag and pol genes in cultured insect cells. With the in vitro mixed lysate assay we have shown that both compounds at 1 μM can completely inhibit the HIV-1 and HIV-2 protease-mediated release of p24 from the HIV-1 gag precursor at pH 5.5 and pH 7.0. In the intracellular baculovirus system these compounds were shown to inhibit the protease-mediated maturation of gag and also the excision of the protease moiety from its precursor. © 1990.
引用
收藏
页码:508 / 511
页数:4
相关论文
共 50 条
  • [31] Natural variation in HIV-1 protease, gag p7 and p6, and protease cleavage sites within Gag/Pol polyproteins: Amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1
    Barrie, KA
    Perez, E
    Lamers, SL
    Farmerie, WG
    Dunn, BM
    Sleasman, JW
    Goodenow, MM
    VIROLOGY, 1996, 219 (02) : 407 - 416
  • [32] The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles
    Chen, SW
    Chiu, HC
    Liao, WH
    Wang, FD
    Chen, SSL
    Wang, CT
    VIROLOGY, 2004, 318 (02) : 534 - 541
  • [33] TRANSLATIONAL FRAMESHIFTING AT THE GAG-POL JUNCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS NOT INCREASED IN INFECTED T-LYMPHOID CELLS
    CASSAN, M
    DELAUNAY, N
    VAQUERO, C
    ROUSSET, JP
    JOURNAL OF VIROLOGY, 1994, 68 (03) : 1501 - 1508
  • [34] HIV Gag and PR: partners in resistance to protease and maturation inhibitors
    Monique Nijhuis
    Retrovirology, 8 (Suppl 2)
  • [35] Human Immunodeficiency Virus gag and protease: partners in resistance
    Fun, Axel
    Wensing, Annemarie M. J.
    Verheyen, Jens
    Nijhuis, Monique
    RETROVIROLOGY, 2012, 9
  • [36] Human Immunodeficiency Virus gag and protease: partners in resistance
    Axel Fun
    Annemarie MJ Wensing
    Jens Verheyen
    Monique Nijhuis
    Retrovirology, 9
  • [37] COMPLEMENTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) GAG PARTICLE FORMATION
    ZHAO, Y
    JONES, IM
    HOCKLEY, DJ
    NERMUT, MV
    ROY, P
    VIROLOGY, 1994, 199 (02) : 403 - 408
  • [38] Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol
    Figueiredo, Anna
    Moore, Katie L.
    Mak, Johnson
    Sluis-Cremer, Nicolas
    de Bethune, Marie-Pierre
    Tachedjian, Gilda
    PLOS PATHOGENS, 2006, 2 (11) : 1051 - 1059
  • [39] Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1
    Hill, MK
    Hooker, CW
    Harrich, D
    Crowe, SM
    Mak, J
    JOURNAL OF VIROLOGY, 2001, 75 (15) : 6835 - 6840
  • [40] Gag-Pol Processing during HIV-1 Virion Maturation: A Systems Biology Approach
    Koennyu, Balazs
    Sadiq, S. Kashif
    Turanyi, Tamas
    Hirmondo, Rita
    Mueller, Barbara
    Kraeusslich, Hans-Georg
    Coveney, Peter V.
    Mueller, Viktor
    PLOS COMPUTATIONAL BIOLOGY, 2013, 9 (06)